- $4.89m
- $7.33m
- $11.42m
Annual cashflow statement for Nexgel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.31 | -4.75 | -3.16 | -3.28 | -2.89 |
| Depreciation | |||||
| Non-Cash Items | 2.04 | 1.88 | 0.116 | 0.149 | 0.374 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.593 | -0.234 | -0.421 | -1.17 | 0.468 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.75 | -2.99 | -3.24 | -3.87 | -1.31 |
| Capital Expenditures | -0.269 | -0.096 | -0.696 | -0.443 | -0.068 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -5.5 | 5.15 | -0.332 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.269 | -5.59 | 4.46 | -0.775 | -0.068 |
| Financing Cash Flow Items | -0.115 | 0 | — | -0.241 | -0.177 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.3 | -3.66 | 0.379 | 3.75 | 0.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.3 | -12.2 | 1.6 | -0.893 | -0.749 |